Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12405993PMC
http://dx.doi.org/10.1093/ofid/ofaf483DOI Listing

Publication Analysis

Top Keywords

high-dose probiotic
4
probiotic mix
4
mix spp
4
spp spp
4
spp prevent
4
prevent antibiotic-associated
4
antibiotic-associated diarrhea
4
diarrhea adults
4
adults multicenter
4
multicenter randomized
4

Similar Publications

Efficacy of spp. Interventions to Modulate Mood Symptoms: A Scoping Review of Clinical Trials.

Int J Mol Sci

August 2025

Escuela de Nutrición y Dietética, Facultad de Medicina y Ciencias de la Salud, Universidad Mayor, Santiago 8580745, Chile.

Probiotics containing spp. have demonstrated immunological and gastrointestinal benefits and may aid in recovery from mood disorders. However, evidence of their mood-modulating efficacy remains inconsistent.

View Article and Find Full Text PDF

WIKIM51 (Wilac D001) improves constipation and gut health in a loperamide-induced mouse model.

Food Funct

August 2025

Department of Food and Nutrition, College of BioNano Technology, Gachon University, Seongnam, Gyeonggi-do 13120, Republic of Korea.

WIKIM51 (Wilac D001) has been reported to reduce body fat, but its potential effects on constipation remain unclear. This study is the first to demonstrate that Wilac D001 alleviates loperamide-induced constipation by enhancing gut barrier function, and modulating gut microbiota. Mice were orally administered vehicle, bisacodyl, low-dose (1 × 10 CFU g), or high-dose (1 × 10 CFU g) Wilac D001 for 4 weeks, and constipation was induced with loperamide (10 mg kg) during the final 11 days.

View Article and Find Full Text PDF

Background: Cholangitis is a clinically significant complication following Kasai portoenterostomy (HPE) in patients with biliary atresia (BA). This meta-analysis aimed to review the available literature on the risk factors for post-Kasai cholangitis.

Methods: The PubMed, Web of Science, Embase, Cochrane Library, Google Scholar and Chinese databases (CNKI, Wanfang, VIP, and SinoMed) were searched to identify relevant studies published until April 2025.

View Article and Find Full Text PDF

Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disorder characterized by immune dysregulation and microbiota imbalances. It affects millions worldwide, leading to significant morbidity and reduced quality of life. The disease is marked by intense pruritus, xerosis, and eczematous lesions, often accompanied by psychological distress and sleep disturbances.

View Article and Find Full Text PDF